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Abstract
Background: Alkoxyethanols (ethylene glycol alkyl ethers) are used as mixtures in a variety of industrial and household prod-
ucts. The aim of this study has been to evaluate the effects of 2-methoxyethanol (ME) and 2-ethoxyethanol (EE) on hematologi-
cal changes induced by 2-butoxyethanol (BE) in rats. Material and Methods: Experiments were performed on male Wistar rats 
treated subcutaneously with BE, ME, and EE alone (in the dose of 0.75 mM/kg/day and 1.25 mM/kg/day) and their mixtures with 
the molar ratio 1:1, for 4 weeks. Hematological analyses were performed on the day 0, 4, 11, 18, and 29. Hemoglobin (HGB) con-
centration in the urine was also determined in the rats treated with BE alone and co-exposed to BE and ME and also BE and EE.  
Results: The rats co-exposed to BE and ME or BE and EE demonstrated significantly less pronounced hematological changes in 
comparison with animals treated with BE alone at the beginning of exposure. At the later period the hematological alterations 
in the same animals were markedly pronounced and progressing with exposure time. The rats co-exposed to BE and ME or BE 
and EE did not demonstrate hemoglobinuria. Conclusions: ME or EE co-administered to rats with BE lead to the amelioration 
in the majority of the hematological parameters at the beginning of the exposure. The hematological changes at the end of the 
co-exposure to BE and ME or BE and EE were markedly pronounced. The effects observed in this study appear to be related with 
metabolic interactions of the examined ether. Med Pr 2015;66(3):303–315
Key words: rats, 2-butoksyethanol, 2-methoxyethanol, 2-ethoxyethanol, interactions, combined exposure
Streszczenie
Wstęp: Alkoksyetanole (etery alkilowe glikolu etylowego) są stosowane jako mieszaniny w  różnych produktach przemysłowych 
i domowych. Celem badania była ocena wpływu 2-metoksyetanolu (ME) i 2-etoksyetanolu (EE) na zmiany hematologiczne indu-
kowane przez 2-butoksyetanol (BE) u szczurów. Materiał i metody: Samce szczurów rasy Wistar narażano drogą podskórną na BE, 
ME lub EE (w dawce 0,75 mM/kg/dzień i 1,25 mM/kg/dzień) oraz na ich mieszaniny w stosunku molowym (1:1) przez 4 tygod-
nie. Badania hematologiczne krwi obwodowej przeprowadzono w  0., 4., 11., 18.  i  29. dniu doświadczenia. Ponadto na początku 
narażenia oznaczono stężenie hemoglobiny w moczu szczurów otrzymujących tylko BE oraz tylko jego mieszaninę z ME lub EE.  
Wyniki: Szczury narażone łącznie na badane związki wykazywały na początku ekspozycji słabiej zaznaczone zmiany hematologicz-
ne niż zwierzęta otrzymujące tylko BE. W późniejszym okresie zmiany te były wyraźne i narastały wraz z czasem trwania naraże-
nia. U szczurów eksponowanych na mieszaniny alkoksyetanoli nie zaobserwowano hemoglobinurii charakterystycznej dla działa-
nia samego BE. Wnioski: Poprawa parametrów hematologicznych na początku narażenia może być spowodowana hamującym dzia-
łaniem ME i EE na metabolizm BE. Z kolei akumulacja kwasów metoksyoctowego i etoksyoctowego, czyli metabolitów odpowied-
nio ME i EE, może być przyczyną wyraźnych zmian hematologicznych na końcu ekspozycji. Med. Pr. 2015;66(3):303–315
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parison with the control group (laminate workers) [13]. 
The frequency of anemia in the group exposed to ME 
was significantly higher as compared to the correspond-
ing control group. While, RBC was significantly nega-
tively associated with air concentrations of ME, HGB, 
PCV, and  RBC were negatively correlated with uri-
nary levels of methoxyacetic acid (MAA), a metabolite 
of  ME. Similarly, in another survey of male workers 
chronically exposed to ME, similar hematological dis-
orders in peripheral blood were observed [14].
In shipyard painters exposed to mixed solvents con-
taining  2-ethoxyethanol acetate it was observed that 
this chemical might be toxic to the bone marrow [15]. 
In the workers exposed to a  low level of BE, a sta-
tistically significant decrease in PCV value and an in-
crease in mean cell hemoglobin concentration (MCHC) 
value were seen [16]. 
Ethylene glycol ether is often used as mixtures 
in industrial or domestic solvent compositions  [17]. 
To our knowledge, there are no studies describing 
the hematological effects of repeated exposure to any 
mixtures of these chemicals in experimental animals. 
The objective of this study has been to evaluate the ef-




The substances: ME, EE, and BE were purchased from 
Sigma-Aldrich Ltd, Poland. Other chemicals were ob-
tained from POCH (Poland). Methoxyethanol, EE, and 
BE solutions and their mixtures were made up in sa-
line, immediately before dosing. 
Animals
Adult male Wistar rats (12  weeks old, with an initial 
body weight about  290  g) were purchased from the 
Jagiellonian University, Pharmacy Breeding Labo-
ratory  (Kraków, Poland). The animals were kept in 
clean polypropylene cages under standard laboratory 
conditions (temperature at  22±2°C, relative humidity 
of 50±10% and a 12/12 h light/dark cycle, the light on 
at  8:00), with food (Murigram, Motycz, Poland) and 
water available ad  libitum. All the treatments were 
started after at least 1 week of acclimatization to labo-
ratory conditions.
All experiments were carried out according to the 
National Institutes of Health Guide for the Care and 
Use of Laboratory Animals, and were approved by 
inTRoducTion
A number of natural and synthetic chemicals are now 
clearly recognized to be both hemopoietic and hemo-
lytic xenobiotics. For example, benzene is a classical he-
mopoietic xenobiotic, for which toxic and leukemogenic 
effects in humans and animal species are well-docu-
mented in the literature  [1,2]. Lead causes inhibition 
of hemoglobin (HGB) biosynthesis and is a causal fac-
tor of hemolytic anemia induced by a decrease in Na+, 
K+-ATPase activity in erythrocytic membrane  [3]. 
Exposure to ethylene glycol ether  (EGEs) and related 
acetates may lead to peripheral hematological disorders 
and bone marrow injuries [4], sometimes complicated 
by aplastic anemia or immunodeficiency. Ethylene gly-
col ether was found to be potent hemopoietic xenobi-
otics in vitro, which acts directly on the hemopoietic 
cells [5].
Ethylene glycol ether, especially  2-methoxyetha-
nol  (ME) (CAS  No.  109-86-4), 2-ethoxyethanol (EE) 
(CAS  No.  110-80-5), and  2-butoxyethanol  (BE) (CAS 
No.  111-76-2), has the unique solvent characteristics, 
i.e.,  solubility in water and organic compounds such 
as oils. The amphiphilic structure, the hydrophilic 
part binds to water, whereas lypophilic part binds to 
oils. The ether is applied to dissolve, extract, suspend, 
dry, and synthesize. Ethylene glycol ether is widely 
used in industry as an ingredient of paints, inks, water-
based cleaners, adhesives, detergents, cosmetics, cut- 
ting fluids, agrochemicals, jet fuels, and hydraulic 
brake fluids [6]. 
Ethylene glycol ether may cause adverse hematolog-
ical effects through inhalation, dermal absorption, and 
ingestion. It was suggested that skin absorption of BE 
is a  predominant factor in occupational exposure  [7]. 
Such ether is oxidized by  NAD-dependent dehydro-
genases in the liver, testicles, and skin  [8,9] to corre-
sponding alkoxyacetic acids  (AAs), which have been 
identified as primary urinary metabolites in humans 
and animals. Alkoxyacetic acids are responsible for 
toxic effects of EGEs  [10]. These metabolites exert in-
hibitory effect on Na+-, K+- and Ca2+-ATPase in eryth-
rocyte membrane in vitro [11].
Data on human exposure to EGEs indicates that ME 
in occupational conditions lead to leucopenia, pancy-
topenia, bone marrow depression, and decline in the 
number of red blood cells  (RBC), and hemoglobin 
concentration  [12]. In male impregnation workers 
chronically exposed to ME, the HGB, packed cell vol-
ume (PCV), and RBC were significantly lower in com-
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the Local Ethics Committee, Kraków, Poland (the cer-
tificate No. 33/2008). 
Animal treatment
The rats were randomly assigned to 11 groups of 5 ani-
mals each. The rats (6 groups) were treated with BE, ME, 
and EE alone in doses of 0.75 and 1.25 mM/kg/day by 
subcutaneous injections at a  fixed volume of  2  ml/kg 
of body weight  (b.w.), regardless of a  dose, once daily, 
5 days per week, for 4 weeks. Other 4 groups of rats were 
exposed to  2-component mixtures of the examined 
compounds, i.e., BE and ME or BE and EE, in the same 
manner and in the same doses with the molar ratio 1:1. 
Control rats (1 group) were given the equivalent volume 
of saline. The applied doses and route of administration 
were chosen based on the previous work output [18].
Blood samples from the tail vein of rats were col-
lected for hematological analyses directly before the 
experiment, during exposure and after its termination, 
i.e., on the day 0, 4, 11, 18, and 29.
Hematological analyses
Data on the hematological analyses has been de-
scribed elsewhere  [18]. Hematological analyses were 
systematically checked. To this end a  standard hu-
man blood  CBC-3D Hematology Control (R&D  Sys-
tem  Inc., Minneapolis, MN, USA) was used. A  day-
to-day precision of RBC, PCV, and mean corpuscular 
volume (MCV) measurements (N = 25) in blood stood 
at 4.4%, 4.8%, and 4.6%, respectively.
Urine examination
Rats treated with BE in a dose of 1.25 mM/kg/day or ex-
posed to BE and ME or BE and EE mixtures in the same 
doses were placed in individual glass metabolic cages 
for urine collection. Urine was collected every day for 
the first 3 days of exposure. Hemoglobin concentration 
was determined by means of Drabkin’s method and 
creatinine level – by means of Jaffe’s reaction. The HGB 
concentration in urine was calculated for 1 g creatinine 
after its determination by Jaffe’s reaction. 
Statistical analyses
All data is expressed as mean  ±  standard deviation. 
Data was analyzed by means of a 2-way analysis of vari-
ance with repeated measures for 1 factor (time or dose) 
and evaluation of simple effects. The analysis was per-
formed with the SPSS 14.0 statistical packet (SPSS Inc., 




2-Butoxyethanol alone, administered in the lower 
dose of 0.75 mM/kg/day caused a significant decrease 
in  RBC on each test day, PCV  – only on the day  4, 
and HGB – on the days 4, 11, and 29 of the experiment. 
Moreover, an increase in both MCV on each test day, 
and reticulocyte (RET) on the days 4, and 11 was ob-
served (Figure 1).
2-Methoxyethanol alone in the same dose as  BE 
(0.75 mM/kg/day) led to only a weakly pronounced but 
statistically significant decrease in RBC on the day 18 
of exposure. In the rats co-exposed to BE and ME in 
the lower doses (0.75 mM + 0.75 mM), significantly less 
pronounced hematological changes vs. BE alone group 
were seen on the days 4 or 4 and 11, mainly in PCV, 
HGB, and RBC, respectively. In these rats significantly 
less pronounced changes in MCV in comparison with 
animals exposed to  BE alone on each test day were 
observed. In a later period, i.e., mainly on the days 18 
and 29 of exposure, the hematological alterations (RBC, 
PCV, HGB, and  RET) in rats simultaneously treated 
with  BE and  ME were similar or more pronounced 
than after BE alone treatment (Figure 1). 
2-Butoxyethanol administration in a  dose of 
1.2 mM/kg/day resulted in a decrease in RBC and also 
in an increase in both MCV, and RET on each test day. 
The decline in  PCV on the days  4  and  18, and  HGB 
on the days 4, 18, and 29 was also observed. In addi-
tion, BE  in the administered dose caused secondary 
hemoglobinuria on the day 1 of exposure. Hemoglob-
in concentrations in urine of treated and control rats 
were 345±6.1  mg/g of creatinine and 43±7.9  mg/g of 
creatinine, respectively. 
2-Methoxyethanol only in the higher dose of 
1.25  mM/kg/day caused a  decrease in  RBC on the 
day 18, and also PCV and HGB on the days 18 and 29 
(Figure 2). 
In the rats co-exposed to BE and ME in the high-
er doses (1.25  mM  +  1.25  mM), significantly less 
pronounced hematological changes in  PCV, HGB, 
and RET, in comparison to the BE alone group on the 
day  4  of exposure were observed. In a  later period, 
i.e., on the days 11, 18, and 29 of exposure, the hemato-
logical alterations (RBC, PCV, HGB, MCV, and RET) 
were similar or greater than in the rats treated with BE 
alone. At the end of the experiment, i.e., on the day 29, 
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RBC – red blood cells / czerwone krwinki, PCV – packed cell volume / hematokryt, HGB – hemoglobin / hemoglobina, MCV – mean corpuscular volume 
of red blood cell / średnia objętość krwinki czerwonej, RET – reticulocytes / retikulocyty.
p ≤ 0.05 significantly different / istotnie różny:
* from control rats / w stosunku do grupy kontrolnej,
** from rats treated with BE alone / w stosunku do grupy narażonej tylko na BE,
*** from rats treated with ME alone / w stosunku do grupy narażonej tylko na ME.
The values are the means ± standard deviation of 5 rats / Wartości przedstawiono jako średnią arytmetyczną ± odchylenie standardowe dla 5 szczurów.
Fig. 1. The effects of combined exposure to 2-butoxyethanol (BE) and 2-methoxyethanol (ME) in the doses of 0.75 mM/kg b.w. on: 
a) RBC, b) PCV, c) HGB, d) MCV, e) RET values in peripheral blood in male rats 
Ryc. 1. Wpływ łącznego narażenia na 2-butoksyetanol (BE) i 2-metoksyetanol (ME) w dawkach 0,75 mM/kg m.c. na: a) RBC, b) PCV, 
c) HGB, d) MCV, e) RET we krwi obwodowej samców szczurów
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Abbreviations as in Figure 1 / Objaśnienia jak na rycinie 1.
Fig. 2. The effects of combined exposure to BE and ME in the doses of 1.25 mM/kg b.w. on: a) RBC, b) PCV, c) HGB, d) MCV, 
e) RET values in peripheral blood in male rats 
Ryc. 2. Wpływ łącznego narażenia na BE i ME w dawkach 1,25 mM/kg m.c. na: a) RBC, b) PCV, c) HGB, d) MCV, e) RET we krwi 
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*** from rats treated with EE alone / w stosunku do grupy narażonej tylko na EE.
Other abbreviations as in Figure 1 / Inne objaśnienia jak na rycinie 1.
Fig. 3. The effects of combined exposure to BE and 2-ethoxyethanol (EE) in the doses of 0.75 mM/kg b.w. on: a) RBC, b) PCV, 
c) HGB, d) MCV, e) RET values in peripheral blood in male rats 
Ryc. 3. Wpływ łącznego narażenia na BE i 2-etoksyetanol (EE) w dawkach 0,75 mM/kg m.c. na: a) RBC, b) PCV, c) HGB, 
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Abbreviations as in Figure 1 and 3 / Objaśnienia jak na rycinie 1 i 3.
Fig. 4. The effects of combined exposure to BE and EE in the doses of 1.25 mM/kg b.w. on: a) RBC, b) PCV, c) HGB, d) MCV, 
e) RET values in peripheral blood in male rats
Ryc. 4. Wpływ łącznego narażenia na BE i EE w dawkach 1,25 mM/kg m.c. na: a) RBC, b) PCV, c) HGB, d) MCV, 
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In contrast, EE  produced less pronounced effects 
on circulating  RBC than  BE or  ME alone. The lower 
dose of  EE (0.75  mM/kg/day) did not induce hema-
tological alterations  (Figure  3). Only the higher dose 
of this compound (1.25  mM/kg) resulted in a  de-
crease in  RBC and  PCV on day  18, and  HGB on the 
days 18 and 29 (Figure 4). 
In the rats concurrently treated with BE and EE in 
the lower doses (0.75  mM/kg  +  0.75 mM/kg), a  sig-
nificantly less pronounced decrease in  RBC than 
in BE alone group was found on the days 4 and 11. In 
a  later period (on the days 18, and 29) the same values 
of  RBC and  HGB, and a  greater decrease in  PCV in 
comparison to BE group were observed. While the in-
crease in MCV was significantly lower than in the rats 
treated with BE alone on each test day, RET were dis-
tinctly elevated on the days 11, 18 and 29 (Figure 3). In 
the rats co-exposed to the higher doses of  BE and  EE 
(1.25 mM/kg + 1.25 mM/kg) the hematological chang-
es were similar (RBC, MCV, and  RET on the days 
from 4 to 29) or more pronounced (PCV and HGB on 
the day 29) than in the rats treated with BE (1.25 mM/kg) 
alone (Figure 4). 
The rats concurrently exposed to BE and ME or BE 
and EE did not demonstrate hemoglobinuria on the 1st 
day of exposure. Hemoglobin concentrations in urine 
of these rats were similar to the control group (66±23.6 
and 62±13.4 mg/g of creatinine, respectively).
Leukocyte alterations
In the rats treated with  BE alone in a  dose of   
0.75  mM/kg/day, white blood cells  (WBC) did not 
change, while lymphocyte (LYM) count was reduced on 
the days 11, 18, and 29 of the experiment. There were no 
significant WBC and LYM alterations in rats exposed 
to  ME alone in a  dose of  0.75  mM/kg/day. The  LYM 
count in the rats co-exposed to the lower doses of BE 
and  ME (0.75  mM  +  0.75  mM) was significantly 
higher in comparison to the group treated with  BE 
alone on the days  11, 18, and  29. These values were 
similar as in the control group on each test day, except 
for the day 29 of the experiment (Figure 5). 
2-Butoxyethanol administration in a  dose of 
1.25  mM/kg/day resulted in a  decrease in  WBC 
on the day  4  and  LYM on the days  18, and  29 of the 
experiment. In rats treated with  ME alone in a  dose 
of  1.25  mM/kg/day, WBC  and LYM  counts were de-
creased on the day  4. No  WBC and  LYM alterations 
in rats co-exposed to BE and ME in the higher doses 
(1.25 mM + 1.25 mM) on any test day were seen, except 
for the day 29 of exposure when LYM count was lower 
than in the control group (Figure 6). 
WBC – white blood cells / białe krwinki, LYM – lymphocytes / limfocyty.
Other abbreviations as in Figure 1 / Inne objaśnienia jak na rycinie 1. 
Fig. 5. The effects of combined exposure to BE and ME in the doses of 0.75 mM/kg b.w. on: a) WBC, b) LYM values 
in peripheral blood in male rats
Ryc. 5. Wpływ łącznego narażenia na BE i ME w dawkach 0,75 mM/kg m.c. na liczbę: a) WBC, b) LYM we krwi obwodowej 
samców szczurów
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No significant changes in  WBC and  LYM count 
were observed in the rats treated with  EE in a  dose 
of  0.75  mM/kg/day. Co-exposure to the lower doses 
of BE and EE (0.75 mM + 0.75 mM) led to the increase 
in LYM on the day 18 in comparison to the rats exposed 
to BE alone. On the day 29 LYM count was similar as in 
the group treated with BE alone but significantly lower 
than in the control group (Figure 7). 
Abbreviations as in Figure 1, 3 and 5 / Objaśnienia jak na rycinie 1, 3 i 5. 
Fig. 7. The effects of combined exposure to BE and EE in the doses of 0.75 mM/kg b.w. on: a) WBC, b) LYM values 
in peripheral blood in male rats
Ryc. 7. Wpływ łącznego narażenia na BE i EE w dawkach 0,75 mM/kg m.c. na liczbę: a) WBC, b) LYM we krwi obwodowej 
samców szczurów
Abbreviations as in Figure 1 and 5 / Objaśnienia jak na rycinie 1 i 5. 
Fig. 6. The effects of combined exposure to BE and ME in the doses of 1.25 mM/kg b.w. on: a) WBC, b) LYM values 
in peripheral blood in male rats 
Ryc. 6. Wpływ łącznego narażenia na BE i ME w dawkach 1,25 mM/kg m.c. na liczbę: a) WBC, b) LYM we krwi obwodowej 
samców szczurów
B. Starek-Świechowicz et al. Nr 3312
The higher dose of  EE (1.25  mM/kg/day) dimin-
ished  WBC on the days  4, 11, and  29 and also re-
duced LYM on the days 11, 18, and 29 in comparison 
to the control group. In the rats concurrently treated 
with BE and EE (1.25 mM + 1.25 mM) WBC count was 
similar as in the control group and significantly higher 
than in the rats exposed to BE (1.25 mM/kg/day) alone 
on the days  11 and  29. On the day  18 this parameter 
did not differ from  BE or  EE groups but was signifi-
cantly lower than in the control group. On the day 29, 
the LYM count in these rats was higher in comparison 
to the rats treated with BE or EE alone and did not dif-
fer vs. control rats. On the days 11 and 18 LYM count 
was lower than in the control group but did not differ 
from groups exposed to BE or EE alone (Figure 8).
discussion
So far, hematological toxicity of EGEs in humans and 
animals has been well documented  [12–14,16,19]. In 
this study a short-chain EGEs (ME and EE) in a rela-
tively low dose (1.25 mM/kg/day) exerted weak hema-
totoxic effects evidenced by reduction in  RBC, PCV, 
HGB, WBC and LYM in peripheral blood. Under the 
same condition of exposure to both kinds of ether 
given separately, in the higher doses (2.5  mM/kg/day 
and 5.0 mM/kg/day), additionally an increase in MCV 
and RET was observed [19]. The results obtained in this 
study indicate that the hematological alterations ex-
pressed mainly in terms of the decrease in RBC, PCV, 
and  HGB seen exclusively at the end of exposure (on 
the days 11, 18 or 29) were rather persistent at low level. 
In principle, no hematological changes in the low level 
dose (0.75 mM/kg/day) of both examined kinds of ether 
were found. Similarly, as in the previous study [19], nei-
ther of these kinds of ether did not induce hemolysis.
Contrary to the ME and EE, the potent hematotoxic 
effects in experimental animals were exerted by  BE. 
This ether alone in relatively low doses (0.75 mM/kg/day 
and  1.25  mM/kg/day), corresponding to below  0.16–
0.26  LD50 p.o. (median lethal dose per  os) value  [20], 
caused considerable hematological changes, including 
the decrease in  RBC, PCV, HGB, WBC, and  LYM as 
well as the increase in MCV, and RET. These changes, 
except for  WBC and  LYM, were most pronounced at 
the beginning of exposure (on the day 4), and then in 
general were regressed despite of exposure duration, 
except for the increase in MCV and RET which were 
persistent during all the exposure period. The lym-
phocytes count was significantly reduced mainly on 
the days  18 and  29 of the experiment. Moreover, BE   
led to apparent hemolysis expressed in the hemoglo-
binuria only on the 1st day of exposure to a higher dose 
of this ether (1.25 mM/kg/day).
Abbreviations as in Figure 1, 3 and 5 / Skróty i objaśnienia jak na rycinie 1, 3 i 5. 
Fig. 8. The effects of combined exposure to BE and EE in the doses of 1.25 mM/kg b.w. on: a) WBC, b) LYM values 
in peripheral blood in male rats 
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It was suggested that hematological disturbances 
induced by  BE in this experiment and the previous 
study [19] are probably the result of the selective hemol-
ysis of the aged erythrocytes. There are many evidences 
that the aging process of RBC leads to several biochem-
ical alterations and to the loss cell deformability and 
the increased MCV value and osmotic fragility [21,22]. 
It seems that selective hemolysis of older erythrocytes 
together with the process of active blood regeneration 
may lead to tolerance development to the hemolytic 
action of  BE  [19,23,24]. On the other hand, the lack 
of tolerance to ME- and EE-induced hemolysis in rats 
treated with these kinds of ether was observed. 
The main aim of this study has been the evaluation 
of the effects of ME and EE on the hematological chang-
es induced by BE in rats. The obtained results show that 
short-chain ether could modify the hematological im-
pact of  BE. This modification, especially by  ME, was 
characterized by  2-step hematological alterations in 
a different manner than those induced by BE alone. At 
the beginning of the exposure (mainly on the day 4), the 
attenuation of the hematotoxic effects of BE expressed 
in terms of higher values of RBC, PCV, and HGB, and 
lower values of MCV and RET as well as the lack of he-
moglobinuria was seen. On the other hand, at the end of 
exposure (from the days 11 to 29) these alterations were 
more pronounced, except for a decrease in MCV for all 
the exposure period and RET on the days 18 and 29 in 
the rats co-exposed to BE and ME in the higher doses 
(1.25 mM/kg/day + 1.25 mM/kg/day). The effects of EE 
on hematological changes induced by BE were less pro-
nounced than ME. 
The obtained data demonstrates that in rats con-
currently treated with  BE and  ME or  BE and  EE the 
hematological changes have the opposite direction of 
the course than those in animals exposed to BE alone. 
Thus, the short-chain ether disturbs the tolerance de-
velopment to the hemolytic action of BE. 
In contrast with the above described chang-
es, in the leukocyte system both kinds of ether 
(ME  in the dose of 0.75 mM/kg/day and EE in doses 
of 0.75 mM/kg/day and 1.25 mM/kg/day) co-adminis-
tered with BE resulted in an increase of the number of 
lymphocytes at the end of exposure. These results are 
insufficient for the suggestion that co-exposure to BE 
and  ME or  BE and  EE may counteract lymphocyto-
penia and immunosuppression induced by each ether 
alone, especially at higher exposure level [19].
In this study, the action of a single compound and 
2-component mixtures: the 1st  one with lipophilic 
properties  (BE) and the  2nd hydrophilic one 
(ME and EE), on the hematological parameters, was ex-
amined. In fact, industry workers are exposed mainly 
to mixtures of EGEs [17]. Also, in household prepara-
tions these kinds of ether occur as mixtures. 
Few studies, in which the mixtures of EGEs or com-
position of these kinds of ether with other chemicals 
were administered, indicate that examined compounds 
could modify each other’s toxic effects. For example, 
ME  attenuated hematotoxic action of isopropoxyetha-
nol  (IPE) in rats at the beginning of the exposure in-
creased its harmful effects at the end of the treatment [18]. 
Aliphatic alcohols, i.e.,  ethanol, n-propanol, and n-bu-
tanol, almost completely inhibited the hemolytic effect 
of BE in rats, and significantly reduced the urinary excre-
tion of butoxyacetic acid (BAA), a metabolite of BE. 
In contrast, co-administration of these alcohols 
with  ME did not change the  24  h urinary excretion 
of MAA. It was suggested that competitive inhibition 
of alcohol dehydrogenase  (ADH) by alcohols results 
in the diversion of  BE metabolism but not ME  [25]. 
In the other study performed on the rats, the intake 
of ethanol along with short-term repeated exposure 
to ME, EE (2.5 mM/kg/day and 5.0 mM/kg/day) or BE 
(0.75 mM/kg/day and 1.25 mM/kg/day) led to marked-
ly ameliorated hematological parameters, as compared 
to those which were altered by these ethers alone [26].
The data cited above indicates that the interactions 
between EGEs exclusively or these kinds of ether and 
other compounds may be related to the metabolism 
of these substances. An increasing body of evidence 
shows that metabolic activation of EGEs to the appro-
priate  AAs is prerequisite for hematotoxic and other 
harmful effects induced by these chemicals [27].
The basal layer of the epidermis contains enzymes 
that have the capacity to metabolize EGEs [28]. How-
ever, it considers that these kinds of ether are mainly 
metabolized by the liver.
Common metabolic pathway of EGEs is via alcohol 
and aldehyde dehydrogenases which lead to the forma-
tion of AAs. The other 2 pathways of BE biotransfor-
mation involve conjugation with glucuronic acid and 
sulfate [27]. Whereas MAA is conjugated with glicine 
to methoxyacetylglicine. No glucuronide of sulphate 
of ME has been observed in urine [25]. 
It was found that BE metabolism to BAA in vivo is 
more efficient than biotransformation of ME to MAA 
and EE to EAA due to the differences in the substrate 
constant (Km) values which decreased with increas-
ing chain length from ME to BE [8]. Thus, at low and 
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similar  EGEs levels, the metabolism of  BE would be 
more efficient than that of the other 2 kinds of glycol 
ether. Moreover, the metabolism of BE is saturated at 
lower concentrations than those of ME and EE. 2-Bu-
toxyacetic acid is not accumulated in the organism 
whereas both MAA and EAA are accumulated [29].
It seems that the effects of ME and EE on the he-
matological alterations induced by  BE are caused by 
metabolic interactions of examined kinds of ether. 
2-Methoxyethanol and EE may inhibit metabolic acti-
vation of BE to BAA and may increase the formation 
of glucuronide and sulphate of BE excreted with urine, 
especially at the beginning of exposure. In the later pe-
riod, at the end of the exposure there is a possibility of 
an increase in AAs levels as a result of their accumula-
tion. These suggestions should be confirmed by subse-
quent studies. 
Finally, it should be taken into account that because 
of the gonadotoxic activity of  ME and  EE, their pro-
duction has been limited whereas the production of BE 
which is regarded as safer from a  toxicological point 
of view increased. Currently, above a 1/2 of household 
preparations contains BE [6]. In this study, the exposure 
to both BE with ME and BE with EE exerted hematotox-
ic effects in rats, especially at the end of the short-term 
repeated exposure. The adverse effects of EGEs indicate 
the need to limit their use, e.g., by larger substitution of 
propylene glycol ether [30]. Occupational exposure to 
mixtures of ether and excessive use of the preparations 
containing EGEs may lead to adverse consequences in 
the hematological system and other organs. 
conclusions
1. The short-term repeated exposure to  BE in rats in 
relatively low doses leads to well-marked hemato-
logical changes which are characteristic of hemo-
lytic anemia.
2. The treatment of rats with  ME or  EE alone in the 
same manner caused relatively less pronounced he-
matological alterations.
3. 2-Methoxyethanol administered to rats exposed 
to BE alone leads to the amelioration in the major-
ity of the hematological parameters and counter- 
acts hemolysis exclusively at the beginning of the 
exposure. 
4. 2-Ethoxyethanol in the same conditions of the ex-
periment exerts qualitatively similar protective ef-
fect but quantitatively less pronounced than ME on 
the hemolytic action of BE.
5. The hematological changes markedly pronounced 
and progressively increased with exposure time at 
the end of the co-exposure to  BE and  ME or  BE 
and  EE as compared with BE alone appear to be 
related with metabolic interactions of these com-
pounds.
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